Allied Market Research

Systemic Lupus Erythematosus Drugs Market Growth Analysis Report Forecasts to 2022

LogoSystemic lupus erythematosus (SLE) is the chronic, autoimmune disorder which involves multiple organ-systems such as heart, kidney, skin, joints, blood, lungs and, in most severe cases, brain. In this disease, the human immune system becomes hyperactive and attacks the normal, healthy tissues of the body. Women from the Asian, Afro-Caribbean and Hispanic descent are chiefly affected by this disease. According to National Institute of Arthritis and Musculoskeletal and Skin Diseases, the prominence of this disease is majorly in the African-American and Asian populations.

Needle Free Injection Systems Market Forecast 2023

LogoNeedle Free Injection Systems include drug delivery systems that drive drugs through the skin play a vital role in the pharmaceutical industry. These systems mark a significant benefit particularly in the developing nations in mass immunization programs to avoid needle stick injuries and other complications that occur due to multiple use of single needle. The major advantage of needle free injection systems is that they provide virtually painless and highly efficient drug delivery. These systems mainly bypass the limitations of the hypodermic needles, which include needle phobia, needle-stick injuries, and lack of reusability.

Kinase Inhibitors Market Value Analysis During Forecast Period of 2014 - 2022

LogoProtein kinase is an enzyme that shuffles protein structure by transferring phosphate collected from ATP(Adenosine Triphosphate) . Protein kinase help in regulating variety of cell functions such as cell cycle, cell differentiation, cell proliferation and apoptosis. These cell processes are used in regulating various cell activities in cancer. The global inhibitors market was valued at approximately $105 billion. Increase in incident of cancer diseases is driving the growth for kinase inhibitor market. According to American Cancer Society, there were more than 1,660,290 new cases diagnosed in 2013. This shows potential for kinase inhibitors in cancer therapies. The growth of kinase inhibitor market is hindered by cost of treatment and lack of funds in conducting research. For Example, the cost of TKI (Tyrosin kinase inhibitors) was approximately $26,400 in non-pharmaceutical spending in 2012.

Digital Supply Chain Industry Set to Boom in 2023

LogoThe demand for Digital Supply Chain is expected to rise globally in the next 4-5 years, owing to various factors such as time and cost effectiveness, rise in usage of digital media devices, and improved service quality over the years. However, lack of security and hacking restrain the growth of the market. Moreover, high growth in market of e-commerce and rise in trend of Internet of Things (IoT) is expected to open new opportunities for the players operating in in the market.

Hormone Refractory Prostate Cancer (HRPCA) Market Report Analysis from 2014 - 2022

LogoHormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, intensifying HRPCA prevalence and fast-emerging treatment modifications, the global Hormone Refractory Prostate Cancer (HRPCA) market is poised to witness an unprecedented growth.

Active Pharmaceutical Ingredients Market Research Analysis and Forecast Report - 2022

LogoActive Pharmaceutical Ingredients are chemically and biologically active components of drugs with direct effect in cure, mitigation, treatment and prevention of diseases. The global API market has witnessed tremendous growth over the last few decades owing to the increased use of drugs and biologics in the treatment of diseases. The increasing adoption of quality standards in API manufacturing such as Good Manufacturing Practices (GMP), current GMP (cGMP), and the global adoption of International Conference on Harmonisation (ICH) guidelines, have helped improve the safety standards. On the other hand, the API industry is facing the challenges such as, shortening the development time, reducing the cost of development, improving the process design and meeting the quality standard without compromising on the profitability.

Instrument Panel Market Explores New Growth Opportunities by 2017-2023

LogoInstrument Panel consists more than half of the cables of any vehicle. In addition, various kinds of displays and switches to control an offbeat across different machines used in the automation industry are fitted in the instrument panel.

Train Control Management System Market to Incur Rapid Extension During 2017 to 2023

LogoGrowth in trend of automated metros and high-speed trains, increase in urbanization across the globe, and rise in fuel emission norms and regulations drive the Train Control and Management System (TCMS) Market. In addition, increase in investments in technology, upgrade of the systems, and increase in demand for safe and comfortable transport also boosts the market. However, a potential malfunction or system failure hinders the growth of the TCMS market.

Active Seat Belt Market in 2017: What Does the Year Ahead Hold?

LogoThe growth of the Active Seat Belt Market is driven by increase in concerns towards safety among people buying cars, rise in incidents of road collision, implementation of stringent regulations towards use of seat belts while driving, and growth in demand for incorporation of safety systems with sensor systems in automobiles. However, difference in opinions regarding safety regulations by the regulatory bodies and increase in overall price of the vehicle restrain the market growth.

Cardiac Equipment Market Size, Share, Analysis and Forecast Report - 2022

LogoCardiovascular diseases (CVD) are one of the foremost public health challenge across the globe. According to World Organization (WHO) estimate, about 17.5 million people died from cardiovascular diseases in 2012, accounting for 31% of all global deaths. Around one third of CVD deaths take place in the low and middle income countries. By the year 2030, more than 23 million people are likely to die annually from cardiovascular diseases. There is an unmet market need for better diagnostics and therapeutics to prevent the mortality from CVDs. Major factors driving the global cardiac equipment market are, rising geriatric population along with higher incidence of coronary artery diseases, stroke, heart failure, hypertension and diabetes. Furthermore, unhealthy sedentary lifestyle, smoking tobacco, and the high intake of salt and cholesterol, supplement the developments in this market. However, the high cost of treatment and a stringent regulatory environment, are likely to restrain the market growth.